Caziant

Adult Dosing .

Dosage forms:  triphasic pack

Special Note

[triphasic pack components]

Info: 28-day pack contains desogestrel/ethinyl estradiol 0.1 mg/25 mcg tab x7, then 0.125 mg/25 mcg tab x7, then 0.15 mg/25 mcg tab x7, then inert tab x7

[additional info]

Info: see Oral Contraceptive Pill (OCP) Hormonal Activity and Therapeutic Equivalence table

contraception

[1 tab PO qd]

Start: day 1 of menstrual cycle or 1st Sunday after onset of menses; Info: D/C >4wk before, restart >2wk after surgery w/ VTE risk; restart >4wk postpartum or >6wk postpartum if breastfeeding

acne vulgaris, moderate (off-label)

[1 tab PO qd]

Start: day 1 of menstrual cycle or 1st Sunday after onset of menses; Info: D/C >4wk before, restart >2wk after surgery w/ VTE risk; restart >4wk postpartum or >6wk postpartum if breastfeeding

dysmenorrhea (off-label)

[1 tab PO qd]

Start: day 1 of menstrual cycle or 1st Sunday after onset of menses; Info: may skip inert tabs for extended or continuous cycle if pain persists; D/C >4wk before, restart >2wk after surgery w/ VTE risk; restart >4wk postpartum or >6wk postpartum if breastfeeding

endometriosis (off-label)

[1 tab PO qd]

Start: day 1 of menstrual cycle or 1st Sunday after onset of menses; Info: may skip inert tabs for extended or continuous cycle if pain persists; D/C >4wk before, restart >2wk after surgery w/ VTE risk; restart >4wk postpartum or >6wk postpartum if breastfeeding

polycystic ovary syndrome (off-label)

[1 tab PO qd]

Start: day 1 of menstrual cycle or 1st Sunday after onset of menses; Info: D/C >4wk before, restart >2wk after surgery w/ VTE risk; restart >4wk postpartum or >6wk postpartum if breastfeeding

renal dosing

[see below]

renal dz: not defined, caution advised

HD/PD: avoid use

hepatic dosing

[see below]

active hepatic dz: contraindicated

Peds Dosing .

Dosage forms:  triphasic pack

Special Note

[triphasic pack components]

Info: 28-day pack contains desogestrel/ethinyl estradiol 0.1 mg/25 mcg tab x7, then 0.125 mg/25 mcg tab x7, then 0.15 mg/25 mcg tab x7, then inert tab x7

[additional info]

Info: see Oral Contraceptive Pill (OCP) Hormonal Activity and Therapeutic Equivalence table

contraception

[postmenarchal females]

Dose: 1 tab PO qd; Start: day 1 of menstrual cycle or 1st Sunday after onset of menses; Info: D/C >4wk before, restart >2wk after surgery w/ VTE risk; restart >4wk postpartum or >6wk postpartum if breastfeeding

acne vulgaris, moderate (off-label)

[postmenarchal females]

Dose: 1 tab PO qd; Start: day 1 of menstrual cycle or 1st Sunday after onset of menses; Info: D/C >4wk before, restart >2wk after surgery w/ VTE risk; restart >4wk postpartum or >6wk postpartum if breastfeeding

dysmenorrhea (off-label)

[postmenarchal females]

Dose: 1 tab PO qd; Start: day 1 of menstrual cycle or 1st Sunday after onset of menses; Info: may skip inert tabs for extended or continuous cycle if pain persists; D/C >4wk before, restart >2wk after surgery w/ VTE risk; restart >4wk postpartum or >6wk postpartum if breastfeeding

endometriosis (off-label)

[postmenarchal females]

Dose: 1 tab PO qd; Start: day 1 of menstrual cycle or 1st Sunday after onset of menses; Info: may skip inert tabs for extended or continuous cycle if pain persists; D/C >4wk before, restart >2wk after surgery w/ VTE risk; restart >4wk postpartum or >6wk postpartum if breastfeeding

polycystic ovary syndrome (off-label)

[postmenarchal females]

Dose: 1 tab PO qd; Start: day 1 of menstrual cycle or 1st Sunday after onset of menses; Info: D/C >4wk before, restart >2wk after surgery w/ VTE risk; restart >4wk postpartum or >6wk postpartum if breastfeeding

renal dosing

[see below]

renal dz: not defined, caution advised

HD/PD: avoid use

hepatic dosing

[see below]

active hepatic dz: contraindicated